Tuchinda Papapit, Kulthanan Kanokvalai, Chularojanamontri Leena, Arunkajohnsak Sittiroj, Sriussadaporn Sutin
1Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Wanglang Road, Bangkoknoi, Bangkok, 10700 Thailand.
2Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Clin Transl Allergy. 2018 Dec 4;8:51. doi: 10.1186/s13601-018-0234-7. eCollection 2018.
Vitamin D has been reported to be associated with many allergic diseases. There are a limited number of the studies of vitamin D supplementation in patients with chronic spontaneous urticaria (CSU). This study aims to study the relationship between vitamin D and CSU in terms of serum vitamin D levels, and the outcomes of vitamin D supplementation.
A literature search of electronic databases for all relevant articles published between 1966 and 2018 was performed. The systematic literature review was done following Preferred Reporting Items for Systematic Reviews and Meta-analysis recommendations.
Seventeen eligible studies were included. Fourteen (1321 CSU cases and 6100 controls) were concerned with serum vitamin D levels in CSU patients. Twelve studies showed statistically significant lower serum vitamin D levels in CSU patients than the controls. Vitamin D deficiency was reported more commonly for CSU patients (34.3-89.7%) than controls (0.0-68.9%) in 6 studies. Seven studies concerned with vitamin D supplementation in CSU patients showed disease improvement after high-dosages of vitamin D supplementation.
CSU patients had significantly lower serum vitamin D levels than the controls in most studies. However, the results did not prove causation, and the mechanisms were not clearly explained. Despite the scarcity of available studies, this systematic review showed that a high dosage of vitamin D supplementation for 4-12 weeks might help to decrease the disease activity in some CSU patients. Well-designed randomized placebo-controlled studies are needed to determine the cut-off levels of vitamin D for supplementation and treatment outcomes.
据报道,维生素D与多种过敏性疾病有关。关于慢性自发性荨麻疹(CSU)患者补充维生素D的研究数量有限。本研究旨在从血清维生素D水平以及补充维生素D的效果方面,研究维生素D与CSU之间的关系。
对1966年至2018年间发表的所有相关文章进行电子数据库文献检索。系统文献综述按照系统评价和Meta分析的首选报告项目建议进行。
纳入了17项符合条件的研究。其中14项(1321例CSU病例和6100例对照)关注CSU患者的血清维生素D水平。12项研究显示,CSU患者的血清维生素D水平在统计学上显著低于对照组。6项研究报告称,CSU患者(34.3 - 89.7%)比对照组(0.0 - 68.9%)更常出现维生素D缺乏。7项关于CSU患者补充维生素D的研究表明,高剂量补充维生素D后疾病有所改善。
在大多数研究中,CSU患者的血清维生素D水平显著低于对照组。然而,结果并未证明存在因果关系,且机制也未得到明确解释。尽管现有研究较少,但该系统评价表明,高剂量补充维生素D 4至12周可能有助于降低部分CSU患者的疾病活动度。需要设计良好的随机安慰剂对照研究来确定补充维生素D的临界水平和治疗效果。